Talking about QoL, Kisqali also improved work productivity in M7, is that unique for Kisqali? ONCOTALKS.EU Powered by Novartis

Joanna Kufel-Grabowska MD, PhD Poznán University of Medical Sciences

Audio: Breast cancer in young women accounts for about 7 to 12% of all breast cancer cases. 1,2 There is an increased number of cases among young women worldwide. Family...Lees meer


Comment on ESMO MCBS ONCOTALKS.EU Powered by Novartis

Christian F Singer, MD, MPH Professor of Clinical-Translational Gynecological Oncology Head Center for Breast Health, Medical University of Vienna

Audio: Dear colleagues, my name is Christian Singer. I am head of the Center for Breast Health at Medical University of Vienna. And today I'm going to talk about the ESMO...Lees meer

1) MONALEESA-7 update van de algehele overleving [POSTER DISCUSSIE]: Tijdens SABCS 2020 is een update gepresenteerd van de algehele overleving van pre- of perimenopausale patienten met HR+, HER2- mBC die in de MONALEESA-7 studie werden behandeld met endocriene therapie in combinatie met ribociclib of placebo.

( Abstract # PD2-04) | Spotlight Poster Discussion | Dec 9...Lees meer


Ask Speakers


Medical Information Request